Background and aims It is not known if new onset diabetes during Coronavirus-19 disease
(COVID-19; NOD COVID) is phenotypically or biochemically different than new onset …

A great global concern is currently focused on the coronavirus disease 2019 (COVID-19)
pandemic and its associated morbidities. The goal of this study was to determine the …

Background and aims We aimed to study newly diagnosed diabetes in patients with mild to
moderate COVID-19. Methods This was a retrospective cohort study of COVID-19 patients …

Aims High rates of newly diagnosed diabetes mellitus (NDDM) have been reported in
association with coronavirus disease-2019 (COVID-19). Factors associated with NDDM and …

Background COVID-19 has a highly variable clinical presentation, ranging from
asymptomatic to severe respiratory symptoms and death. Diabetes seems to be one of the …

Abstract Aims Coronavirus disease 19 (COVID-19) has become a pandemic. Diabetic
patients tend to have poorer outcomes and more severe disease (Kumar et al. in Diabetes …

Background and aims To study the prevalence and impact of diabetes mellitus and other
comorbidities among hospitalized patients with COVID-19. Methods In a prospective …

Diabetes and Covid-19 Diabetes is associated with an increased risk of severe Covid-19.
New-onset diabetes and metabolic complications of preexisting diabetes, including diabetic …

Background and aims This study investigated the clinical manifestations, outcomes and long-
term complications of COVID-19 inpatients in southern part of Bangladesh while …

Introduction The COVID-19 pandemic disproportionately affected patients who had
comorbid diabetes mellitus. COVID-19 patients with diabetes experience significantly higher …